Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Aurora Cannabis Inc.TSX: ACB.TO

Revenue · Q4 FY2026 · quarter ended Mar 2026

Revenue declines year over year

Q4 FY2026 revenue of CA$38.01M fell 58.0% year over year, behind the -7.2% change in trailing-twelve-month revenue. Sequentially, it fell 59.6% from the prior quarter. Over 3 fiscal years it compounded at +11.2% a year.

Context

  • Revenue increased in 2 of the last 3 fiscal years.

What to watch

Whether revenue reaches the consensus estimate from 4 analysts of CA$314.3M (-2.0%) for the fiscal year ending Mar 2027, a step up from the -6.6% reported in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$38.01M-59.6% QoQ
Last fiscal yearMar 2026
CA$320.59M-6.6% YoY
LTMMar 2026
CA$318.43M-7.2% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-58.0%-31.2%+26.8 pp
1 year-6.6%-2.0%+4.6 pp
3-year CAGR+11.2%+6.3%-4.9 pp
5-year CAGR+8.2%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

CAD · from the income statement

Latest · FY2026
320.59M CAD
Year-over-year change
-6.6%
4-year CAGR
+9.7%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -7.2% is the 7th highest of 8, against a peer median of +26.1%.
  • Over three fiscal years its annual growth of +11.2% compares with a peer median of +15.3%.
ACB.TO Competitors
Revenue for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$318.43M CAD-7.2%+11.2%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$310.92M CAD+15.6%-5.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$274.19M CAD+41.3%—
TSND.TOTerrAscend Corp.LTM Mar 2026$261.74M USD-8.7%+3.3%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$158.57M CAD+22.2%+17.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$51.17M USD+65.5%+207.5%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$50.92M USD+28.9%+35.4%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$2.76M CAD+26.1%+13.6%
Peer median (excluding ACB.TO) —+26.1%+15.3%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.